NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 121 filers reported holding NUVATION BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $868,201 | +109.9% | 297,329 | +161.6% | 0.00% | – |
| Q1 2024 | $413,697 | +57.9% | 113,653 | -34.5% | 0.00% | – |
| Q4 2023 | $262,062 | +1852.9% | 173,551 | +1633.1% | 0.00% | – |
| Q3 2023 | $13,419 | -78.2% | 10,014 | -70.7% | 0.00% | – |
| Q2 2023 | $61,544 | -85.5% | 34,191 | -86.6% | 0.00% | – |
| Q1 2023 | $424,331 | +39.9% | 255,621 | +61.8% | 0.00% | – |
| Q4 2022 | $303,396 | -13.8% | 158,019 | +0.5% | 0.00% | – |
| Q3 2022 | $352,000 | -43.6% | 157,182 | -18.4% | 0.00% | – |
| Q2 2022 | $624,000 | +387.5% | 192,581 | +690.5% | 0.00% | – |
| Q1 2022 | $128,000 | -29.3% | 24,362 | +14.4% | 0.00% | – |
| Q4 2021 | $181,000 | -11.7% | 21,292 | +3.1% | 0.00% | – |
| Q3 2021 | $205,000 | +69.4% | 20,650 | +59.2% | 0.00% | – |
| Q2 2021 | $121,000 | -31.2% | 12,973 | -23.0% | 0.00% | – |
| Q1 2021 | $176,000 | – | 16,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,247,340 | $49,401,000 | 15.77% |
| Aisling Capital Management LP | 2,541,009 | $8,233,000 | 5.87% |
| EDBI Pte Ltd | 1,270,504 | $4,116,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $3,684,000 | 3.36% |
| Deep Track Capital, LP | 11,471,281 | $37,167,000 | 2.44% |
| EcoR1 Capital, LLC | 13,896,543 | $45,025,000 | 1.55% |
| Boxer Capital, LLC | 4,341,009 | $14,065,000 | 0.89% |
| Baupost Group | 10,418,194 | $33,755,000 | 0.50% |
| Redmile Group, LLC | 3,471,709 | $11,248,000 | 0.43% |
| 683 Capital Management, LLC | 1,766,657 | $5,724,000 | 0.40% |